Geneos Wealth Management’s FT Vest US Equity Max Buffer ETF March MARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Buy
2,960
+130
+5% +$4.41K ﹤0.01% 1211
2026
Q1
$94.7K Hold
2,830
﹤0.01% 1191
2025
Q4
$93.5K Hold
2,830
﹤0.01% 1167
2025
Q3
$92.3K Hold
2,830
﹤0.01% 1151
2025
Q2
$90.9K Buy
2,830
+1,350
+91% +$42.6K ﹤0.01% 1288
2025
Q1
$46.4K Hold
1,480
﹤0.01% 1514
2024
Q4
$45.7K Buy
+1,480
New +$45.5K ﹤0.01% 1350

Other funds holding MARM

Geneos Wealth Management's MARM Position: Q2 2026 in Review

Geneos Wealth Management increased its FT Vest US Equity Max Buffer ETF March (MARM) stake by 4.6% in Q2 2026, buying an estimated $4.41K and bringing the position to 2,960 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

Geneos Wealth Management first reported a position in MARM in Q4 2024 and has held it in 7 quarters since. 75 funds tracked by Wall St. Rank hold MARM as of Q2 2026.

  • Geneos Wealth Management held 2,960 shares of FT Vest US Equity Max Buffer ETF March worth $101K as of Q2 2026.
  • Geneos Wealth Management bought 130 FT Vest US Equity Max Buffer ETF March shares in Q2 2026, an estimated $4.41K.
  • FT Vest US Equity Max Buffer ETF March made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1211 holding.
  • Geneos Wealth Management first reported a position in FT Vest US Equity Max Buffer ETF March in Q4 2024 and has held it in 7 quarters since.
  • 75 funds tracked by Wall St. Rank held FT Vest US Equity Max Buffer ETF March as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.